Trial
NCT00925652
Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Dana-Farber Cancer Institute
Collaborators
Brigham and Women's Hospital; Beth Israel Deaconess Medical Center; Translational Breast Cancer Research Consortium; Genentech, Inc.
Condition
Breast Cancer
Intervention
Bevacizumab
Why stopped
The study was terminated early due to slow accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-01-19